Buscar
Congreso SOLACI
Home Tags Transcatheter aortic valve replacement

Tag: transcatheter aortic valve replacement

06/10 | SOLACI Webinar – Pressure Gradients After TAVR: Paradigm Shift?

solaci - 0
Evolut Low Risk

EuroPCR 2021 | Evolut Low Risk: Two-Year Results of The Self-Expanding...

solaci - 0

15/05 | SOLACI@Medtronic: Structural Heart Fellowship Program Support: Mastering TAVI Implant

solaci - 0

Validating Consensus on Post TAVR Conduction Disturbances in the Clinical Practice

solaci - 0
El aumento de la experiencia de los operadores mejora los resultados en el TAVI

ST-Segment Elevation Infarction After TAVR: Problems in Every Aspect

solaci - 0
nefroproteccion

Incidence, Predictors, and Results of Acute Kidney Injury in Patients Undergoing...

solaci - 0
Webinar SOLACI | TAVI en pacientes de bajo riesgo

06/05 | SOLACI Webinar: TAVI in Low-Risk Patients

solaci - 0
duración terapia de doble antiagregación plaquetaria

Dual Antiplatelet Therapy and TAVR: Obsolete Guidelines

solaci - 0
Webinar SOLACI | TAVI TALKS: Por qué la hemodinamia realmente importa

29/04 | Webinar SOLACI – TAVI TALKS: Why Hemodynamics Really Matters

solaci - 0
TAVI SURAVI

TAVR vs. the Least Invasive Surgically Implanted Valve

solaci - 0
1...789...28Page 8 of 28

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad